Medicare Enrolled

Dr. Thomas Polascik, M.D.

Urology Physician · Durham, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
DUKE CANCER CENTER 5-1 UROLOGY, Durham, NC 27710
9196844946
In practice since 2006 (19 years)
NPI: 1083798979 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Polascik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Polascik? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Polascik

Dr. Thomas Polascik is an urology physician in Durham, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Polascik performed 651 Medicare services across 605 unique beneficiaries.

Between the years covered by Open Payments, Dr. Polascik received a total of $38,310 from 18 pharmaceutical and/or device companies across 42 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Polascik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 651 Medicare services $38,310 industry payments

Medicare Practice Summary

Medicare Utilization ↗
651
Medicare services
Bottom 29% in NC for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
605
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
90 $91 $573
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
87 $22 $180
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
83 $100 $344
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
78 $59 $255
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
71 $24 $200
New patient office visit, complex (60-74 min) 52 $121 $490
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $44 $172
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
43 $51 $590
Prostate destruction with imaging guidance
This procedure involves destroying prostate tissue using energy or other methods while using imaging technology to guide the treatment.
29 $567 $16,708
Temporary urethral stent insertion
A temporary stent is placed in the urethra using an endoscope to keep the passage open.
28 $32 $1,903
Other procedure on male genital system
A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories.
27 $97 $481
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $93 $390
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.3% high complexity
42.5% medium
53.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$38,310
Total received (2018-2024)
Avg $6,385/year across 6 years
Top 6% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
42
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,858 (67.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,697 (17.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,755 (15.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,994
2023
$199
2021
$13,370
2020
$11,967
2019
$4,273
2018
$508

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Edap Technomed Inc
$3,635
Janssen Scientific Affairs, LLC
$2,028
Ethicon Endo-Surgery Inc.
$1,012
INTUITIVE SURGICAL, INC.
$906
AngioDynamics, Inc.
$164
Dendreon Pharmaceuticals LLC
$141
Medical Device Business Services, Inc.
$108
Top 3 companies account for 83.5% of 2024 payments
All-time payments by company (2018-2024) ›
AngioDynamics, Inc.
$10,958
PFIZER INC.
$9,697
Varian Medical Systems, Inc.
$6,414
Edap Technomed Inc
$3,635
Progenics Pharmaceuticals, Inc.
$2,600
Janssen Scientific Affairs, LLC
$2,028
Ethicon Endo-Surgery Inc.
$1,012
INTUITIVE SURGICAL, INC.
$906
OPKO Pharmaceuticals, LLC
$248
Clinical Laserthermia Systems Americas Inc.
$174
Dendreon Pharmaceuticals LLC
$141
HealthTronics Mobile Solutions, LLC
$125
Medical Device Business Services, Inc.
$108
COMSORT, Inc
$100
Coloplast Corp
$83
Endocare, Inc.
$37
Blue Earth Diagnostics Limited
$24
Intuitive Surgical, Inc.
$19
Top 3 companies account for 70.7% of all-time payments
Associated products mentioned in payments ›
ALTIS · Axumin · Da Vinci Surgical System · ERLEADA · Endocare Cryocare System · KEYTRUDA · MOBILE LASER UNIT · NANOKNIFE · NanoKnife · PROVENGE · PYLARIFY · Rayaldee · SUTENT · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for urology physician in NC.

Looking for an urology physician in Durham?
Compare urology physicians in the Durham area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Polascik is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 6% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Polascik experienced with prostate gland biopsy?
Based on Medicare claims data, Dr. Polascik performed 90 prostate gland biopsy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Polascik receive payments from pharmaceutical companies?
Yes. Dr. Polascik received a total of $38,310 from 18 companies across 42 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Polascik's costs compare to other urology physicians in Durham?
Dr. Polascik's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Polascik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →